AbbVie today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of epcoritamab, a T-cell engaging bispecific antibody, and lenalidomide, compared to rituximab ...
The institutional banking provider is expanding into digital asset custody, liquidity and execution services as former Zodia Custody CEO John Cronin takes the helm. BTC added 0.6% to $59,800 to start ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results